The Cooper Companies, Inc. (NASDAQ:COO) Position Increased by Azzad Asset Management Inc. ADV

Azzad Asset Management Inc. ADV raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 300.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,360 shares of the medical device company’s stock after buying an additional 14,521 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in Cooper Companies were worth $1,964,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Treasurer of the State of North Carolina lifted its stake in Cooper Companies by 0.9% during the fourth quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock valued at $8,652,000 after buying an additional 212 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Cooper Companies by 55.3% in the fourth quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock worth $33,188,000 after purchasing an additional 31,234 shares in the last quarter. Gulf International Bank UK Ltd lifted its position in shares of Cooper Companies by 300.0% in the first quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock worth $1,739,000 after purchasing an additional 12,861 shares in the last quarter. Parkman Healthcare Partners LLC lifted its position in shares of Cooper Companies by 15.1% in the fourth quarter. Parkman Healthcare Partners LLC now owns 75,183 shares of the medical device company’s stock worth $28,452,000 after purchasing an additional 9,862 shares in the last quarter. Finally, Czech National Bank lifted its position in shares of Cooper Companies by 303.2% in the first quarter. Czech National Bank now owns 34,968 shares of the medical device company’s stock worth $3,548,000 after purchasing an additional 26,295 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on COO shares. Robert W. Baird increased their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Piper Sandler reissued an “overweight” rating and issued a $115.00 price target on shares of Cooper Companies in a research report on Wednesday. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Citigroup increased their price objective on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Redburn Atlantic upgraded Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price objective on the stock in a report on Tuesday, March 19th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $111.42.

Cooper Companies Trading Down 1.2 %

Shares of COO stock opened at $85.51 on Thursday. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $104.07. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34. The business’s 50 day moving average is $92.46 and its two-hundred day moving average is $94.71. The company has a market cap of $17.03 billion, a PE ratio of 50.23, a price-to-earnings-growth ratio of 2.14 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. The company had revenue of $942.60 million for the quarter, compared to the consensus estimate of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.77 earnings per share. Equities analysts predict that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.